These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8597321)

  • 1. Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.
    Trapnell CB; Narang PK; Li R; Lavelle JP
    Ann Intern Med; 1996 Mar; 124(6):573-6. PubMed ID: 8597321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole.
    Trapnell CB; Jamis-Dow C; Klecker RW; Collins JM
    Antimicrob Agents Chemother; 1997 May; 41(5):924-6. PubMed ID: 9145845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics.
    Jordan MK; Polis MA; Kelly G; Narang PK; Masur H; Piscitelli SC
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2170-2. PubMed ID: 10898693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
    Clin Pharmacol Ther; 2004 Dec; 76(6):579-87. PubMed ID: 15592329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus.
    Gallicano K; Khaliq Y; Carignan G; Tseng A; Walmsley S; Cameron DW
    Clin Pharmacol Ther; 2001 Aug; 70(2):149-58. PubMed ID: 11503009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
    Clin Pharmacol Ther; 2004 Oct; 76(4):313-22. PubMed ID: 15470330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin levels may increase with fluconazole during MAC treatment.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361528
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus.
    Schimkat M; Althaus C; Becker K; Sundmacher R
    Ger J Ophthalmol; 1996 Jul; 5(4):195-201. PubMed ID: 8854102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
    Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
    Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
    Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
    Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.
    Li RC; Narang PK; Sahai J; Cameron W; Bianchine JR
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1566-70. PubMed ID: 9210686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
    Boulanger C; Hollender E; Farrell K; Stambaugh JJ; Maasen D; Ashkin D; Symes S; Espinoza LA; Rivero RO; Graham JJ; Peloquin CA
    Clin Infect Dis; 2009 Nov; 49(9):1305-11. PubMed ID: 19807276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.
    Holmberg SD; Moorman AC; Von Bargen JC; Palella FJ; Loveless MO; Ward DJ; Navin TR
    JAMA; 1998 Feb; 279(5):384-6. PubMed ID: 9459473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpigmentation in a patient with AIDS, receiving rifabutin for disseminated Mycobacterium genavense infection.
    Figueras C; Garcia L; Bertran JM
    Eur J Pediatr; 1998 Jul; 157(7):612. PubMed ID: 9686833
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Pakuts A; Cameron DW
    J Infect Dis; 1994 May; 169(5):1103-7. PubMed ID: 8169401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
    Weiner M; Benator D; Peloquin CA; Burman W; Vernon A; Engle M; Khan A; Zhao Z;
    Clin Infect Dis; 2005 Nov; 41(9):1343-9. PubMed ID: 16206114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.
    Brown LS; Sawyer RC; Li R; Cobb MN; Colborn DC; Narang PK
    Drug Alcohol Depend; 1996 Dec; 43(1-2):71-7. PubMed ID: 8957145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.